Katogen BoardMemos™Board-ready regulatory, business development, intellectual property, and payer due diligence - delivered as complete, operator-grade reports created in minutes.

The only operator-encoded due-diligence assessment that reads like a 35-year veteran's private memo to the board - complete with dataroom checklists, critical-path timelines, differentiation scenarios, strategic options, and explicit licensing recommendations.

No junior analysts. No six-figure consulting invoice. Just elite intelligence that accelerates term sheets and IND filings.

Most regulatory reviews are generic slide decks.

Katogen BoardMemos are different - they are the exact 30-40 page playbook an experienced operator would hand the board before opening licensing conversations.

Process

How it works

  1. 1

    Input a short brief

    Anchor the memo with your program facts, indication priority, and deal context - the same inputs a boutique diligence team would request in week one.

  2. 2

    BoardMemos™ are delivered in minutes

    Built on 35+ years of real acquisitions and regulatory judgment - not a generic slide outline. You get narrative depth, ranked options, and explicit commercial significance.

  3. 3

    Download a dataroom-ready PDF

    Primary-source citations, Decision / Reversibility sections, strategic options tables, and checklists your team can immediately use.

Differentiation

Why BoardMemos are different

  • True diligence grade

    Executive thesis, artifact checklists, IND critical path, competitive matrix, payer hypotheses, and bull/bear triggers - not a literature review.

  • Operator scar tissue

    Encoded by Doug Drysdale - 17 closed acquisitions, USD 4B+ raised - so the memo reads like a seasoned operator wrote it for the board.

  • Dataroom-ready today

    Structured for how BD, IC, and regulatory affairs teams actually consume diligence - forwardable, quotable, and action-oriented.

  • Minutes, not months

    Replace two to four weeks and roughly USD 20k-75k of traditional boutique or Big-4 scoping for an in-depth ~30 page board memo in minutes.

Pricing

Exceptional Value

Standalone BoardMemo - $1,299

One asset-specific, fully cited, board-ready due-diligence report. Perfect for seed raises, BD outreach, or investor deep-dives.

Purchase BoardMemo

Annual Unlimited - $20,000/year

Billed annually

Unlimited BoardMemos for your entire team, shared folders, custom templates, and priority support. The equivalent of a fractional Chief Strategy Officer on retainer for less than one traditional engagement per quarter.

Contact for Annual Unlimited

Social proof

What leaders say

“Thank you for this genuinely impressive work, the framework has real depth.”
- Preclinical CEO, GLP-1 asset
“Love the report. What I appreciated was the regulatory analysis as well as the capital and market risk analyses.”
- Biotech COO

Next step

Ready to put a premium due-diligence memo in front of your board or next partner?